| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 03/18/2004 | WO2004022562A1 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| 03/18/2004 | WO2004022537A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/18/2004 | WO2004010512A9 Heteroatom-containing diamondoid transistors |
| 03/18/2004 | WO2004006355A3 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053913 Process for preparing 6-alkylidene penem derivatives |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/17/2004 | CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof |
| 03/16/2004 | US6706736 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049043 N-alkoxy-4,4-dioxy-polyalkyl-piperidine compounds, with glycidyl or alkylcarbonyl groups as functional initiators for controlled radical polymerization |
| 03/11/2004 | US20040048878 Heterocyclic compounds |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/10/2004 | CN1481363A N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/04/2004 | WO2004018479A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 03/04/2004 | WO2004017961A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003049527A3 Mitotic kinesin inhibitors |
| 03/04/2004 | US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders |
| 03/04/2004 | US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists |
| 03/04/2004 | US20040043978 Tricyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/03/2004 | EP1392701A1 Compounds and pharmaceutical compositions for inhibiting mrp1 |
| 03/03/2004 | EP1392700A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene |
| 03/03/2004 | EP1392699A1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/03/2004 | EP1392697A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino 2,3-f]quinoline |
| 03/03/2004 | EP1392686A1 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392312A1 TRIAZOLO 4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/03/2004 | EP0906313B1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 03/03/2004 | EP0758333B1 Intermediates in pharmaceutical camptothecin preparation |
| 03/02/2004 | US6699989 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/02/2004 | US6699975 Fluorescent quenching detection reagents and methods |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040038967 Novel carbapenem derivatives |
| 02/26/2004 | US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014361A1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 02/19/2004 | WO2004014150A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 02/19/2004 | US20040034221 Enzyme inhibitors for treating AIDS |
| 02/19/2004 | US20040034052 Antitumor agents |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034014 3,7-dihydro-purine-2,6-dione derivatives useful for treating obesity and type II diabetes |
| 02/19/2004 | US20040033964 For treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation |
| 02/19/2004 | US20040031951 Alkylenedioxythiophene dimers and trimers |
| 02/19/2004 | DE19600707B4 Biyclische Anhydrid-Wirkstoff-Verbindungen, Verfahren zur Herstellung und Verwendung derselben Biyclische anhydride-drug compounds, methods of preparation and use thereof |
| 02/18/2004 | EP1000086B1 Alatrofloxacin parenteral compositions |
| 02/18/2004 | CN1138777C Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
| 02/17/2004 | US6693197 Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline |
| 02/17/2004 | US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 02/12/2004 | WO2004013297A2 Manzamine-producing actinomycetes |
| 02/12/2004 | WO2004012671A2 Substituted furo [2,3-b] pyridine derivatives |
| 02/12/2004 | US20040030078 Novel photochromic polymers and methods of synthesizing same |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029915 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof |
| 02/12/2004 | US20040029908 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 02/12/2004 | CA2494775A1 Manzamine-producing actinomycetes |
| 02/11/2004 | EP1387845A2 PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE |
| 02/11/2004 | CN1474703A Taxoid conjugates as antimitotic and antitumor agents |
| 02/10/2004 | US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/05/2004 | US20040023970 Method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I |
| 02/05/2004 | US20040023947 Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/05/2004 | US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/05/2004 | US20040021204 Heteroatom-containing diamondoid transistors |
| 02/05/2004 | DE10231368A1 Verfahren zur Herstellung von Imidazoliumsalzen Process for the preparation of imidazolium salts |
| 02/04/2004 | EP1385524A1 Pyrazolopyrimidines as therapeutic agents |
| 02/04/2004 | CN1473163A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1472212A Substituted carbolnie metal complex and application thereof |
| 02/04/2004 | CN1472211A Biporphin metal coordination compound with bridge linking face-face structure and its use |
| 02/03/2004 | US6686385 Anhydro sugar derivatives of indolocarbazoles |
| 02/03/2004 | US6686374 Azaindoles having serotonin receptor affinity |
| 01/29/2004 | WO2004010512A2 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | WO2004009602A1 Pyrazolopyrimidines as kinase inhibitors |
| 01/29/2004 | WO2004009600A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/29/2004 | WO2003076439A3 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine |
| 01/29/2004 | US20040019070 Nitrogen compounds used as opiate receptor agonists or antagonists, for prophylaxis of drug abuse, cardiovascular, respiratory system, gastrointestinal disorders, as analgesics, antitussives or immunosuppressants |
| 01/29/2004 | CA2492704A1 Heteroatom-containing diamondoid transistors |
| 01/29/2004 | CA2491251A1 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/28/2004 | EP1383774A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |